Botox on The Rest Is Politics: US

The Rest Is Politics: USJuly 24, 2026

The Leadership Mistake Almost Everyone Makes (Adam Grant)

0:47
mid-roll
Anthony Scaramucci, Katty Kay
Speaker
Goalhanger
July 24, 2026
Announcer-readBrand awarenessDynamic insertionHealth & Wellness
0:00 / 0:47
@ 20:17 in ep

Estimated current placement value

Low confidence
~$240range $36$1,700

What a comparable one-episode placement on this show might cost today—not reported advertiser spend or a historical invoice.

How this estimate works

A broad audience range for the top 2,000 popularity tier is multiplied by public CPM benchmarks and a placement factor. Inputs for this read: 0:47 · Announcer-read · mid-roll.

Model placement-value-v1-2026-08 · benchmark inputs as of 2026-08
Methodology and limitations →

Transcript

Chronic migraine. 15 or more headache days a month, each lasting 4 hours or more, can make me feel like a spectator in my own life. Botox, onabotulinum toxin A, prevents headaches in adults with chronic migraine. It's not for those with 14 or fewer headache days a month. It's the number one prescribed branded chronic migraine preventive treatment. Prescription Botox is injected by your doctor. Effects of Botox may spread hours to weeks after injection, causing serious symptoms. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems or muscle weakness can be signs of a life-threatening condition. Patients with these conditions before injection are at highest risk. Side effects may include allergic reactions, neck and injection site pain, fatigue and headache. Allergic reactions can include rash, welts, asthma symptoms and dizziness. Don't receive Botox if there's a skin infection. Tell your doctor your medical history, muscle or nerve conditions including ALS Lou Gehrig's disease, myasthenia.

Auto-transcribed · verbatim audio matches · Report an error

Episode

The Rest Is Politics: US
The Leadership Mistake Almost Everyone Makes (Adam Grant)
Hosts: Anthony Scaramucci, Katty Kay
Publisher: Goalhanger